rucaparib,nivolumab
clovis oncology,bms
['rucaparib', 'gog-3020', 'ovarian', 'athena mono']
top abstract #asco22 athena mono (gog-3020/engot-ov45): a randomized, double-blind, phase 3 trial evaluating rucaparib monotherapy versus placebo as maintenance treatment following response to first-line platinum-based chemotherapy in ovarian cancer. 
Vivek Subbiah, MD, (@VivekSubbiah) #PrecisionMedicine Expert and Medical Oncologist, takes over our Twitter today to discuss #ASCO22.